PRAH - PRA Health Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

PRA Health Sciences, Inc.

4130 ParkLake Avenue
Suite 400
Raleigh, NC 27612
United States
919-786-8200
http://prahs.com

SectorHealthcare
IndustryDiagnostics & Research
Full Time Employees16,000

Key Executives

NameTitlePayExercisedYear Born
Mr. Colin ShannonChairman, CEO & Pres1.52MN/A1959
Mr. Michael J. BonelloExec. VP, CFO & Corp. Sec.659.05k2.69M1970
Mr. Kent ThoelkeExec. VP & Chief Scientific OfficerN/AN/AN/A
Mr. Thomas ByrneVP of Legal AffairsN/AN/AN/A
Christine RogersDirector of PR & Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services. It also provides strategic solutions, such as embedded, functional services provider, staff augmentation, and custom-built development solutions, as well as commercialization services; and early development services for Phase I and Phase IIa studies, and bioanalytical analysis. The Data Solutions segment offers data, analytics, technology, and consulting solutions to the life sciences market. Its services include market intelligence services, such as targeting and compensation, and pharmaceutical audit suite services; consulting and services comprising brand analytics, managed markets, commercial effectiveness, and scientific studies/clinical hubs; and technology-enabled products and services. PRA Health Sciences, Inc. conducts clinical trials in the areas of pharmaceutical development, including oncology, immunology, central nervous system, inflammation, respiratory, cardio metabolic, and infectious diseases. The company was formerly known as PRA Global Holdings, Inc. and changed its name to PRA Health Sciences, Inc. in July 2014. PRA Health Sciences, Inc. was founded in 1976 and is headquartered in Raleigh, North Carolina.

Corporate Governance

PRA Health Sciences, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 6. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 8; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.